您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Cefuroxime-d3
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Cefuroxime-d3
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Cefuroxime-d3图片
CAS NO:1803240-98-3
包装:1mg
市场价:3614元

产品介绍
An internal standard for the quantification of cefuroxime
Cas No.1803240-98-3
Canonical SMILESO=C(OCC(CS[C@@]1([C@@H](C(N21)=O)NC(/C(C3=CC=CO3)=N\OC([2H])([2H])[2H])=O)[H])=C2C(O)=O)N
分子式C16H13D3N4O8S
分子量427.4
溶解度DMSO: slightly soluble,Methanol: slightly, heated
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Cefuroxime-d3is intended for use as an internal standard for the quantification of cefuroxime by GC- or LC-MS. Cefuroxime is a cephalosporin antibiotic with broad-spectrum activity against Gram-positive and Gram-negative bacteria includingS. pyogenes,S. pneumoniae,S. viridans,E. coli,P. mirabilis,H. influenzae, andN. gonorrhoeae(mean MICs = 0.005-8.2 μg/ml).1Like other cephalosporins, cefuroxime inhibits peptidoglycan crosslinking and bacterial cell wall synthesis.2It is resistant to hydrolysis by bacterial β-lactamases, increasing its efficacy against β-lactamase-producing Gram-negative bacteria.3Cefuroxime is protective against Gram-positive and Gram-negative infectionsin vivowith mean ED50values ranging from 2 to 35 and 1 to 55 mg/kg, in mice and rats, respectively.4Formulations containing cefuroxime have been used to treat urinary tract infections.

1.O'Callaghan, C.H., Sykes, R.B., Griffiths, A., et al.Cefuroxime, a new cephalosporin antibiotic: Activity in vitroAntimicrob. Agents Chemother.9(3)511-519(1976) 2.Curtis, N.A.C., Hughes, J.M., and Ross, G.W.Inhibition of peptidoglycan cross-linking in growing cells of Escherichia coli by penicillins and cephalosporins, and its prevention by R factor-mediated beta-lactamaseAntimicrob. Agents Chemother.9(2)208-213(1976) 3.Richmond, M.H., and Wotton, S.Comparative study of seven cephalosporins: Susceptibility to beta-lactamases and ability to penetrate the surface layers of Escherichia coliAntimicrob. Agents Chemother.10(2)219-222(1976) 4.Ryan, D.M., O'Callaghan, C.H., and Muggleton, P.W.Cefuroxime, a new cephalosporin antibiotic: Activity in vivoAntimicrob. Agents Chemother.9(3)520-525(1976)